No abstract available
MeSH terms
-
Aminopyridines / pharmacology*
-
Aminopyridines / therapeutic use*
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Agents / therapeutic use*
-
Benzimidazoles / pharmacology*
-
Benzimidazoles / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / metabolism
-
Cell Cycle / drug effects*
-
Clinical Trials, Phase I as Topic
-
Cyclin-Dependent Kinase 4 / antagonists & inhibitors*
-
Cyclin-Dependent Kinase 6 / antagonists & inhibitors*
-
Female
-
Humans
-
Piperazines / pharmacology*
-
Piperazines / therapeutic use*
-
Proto-Oncogene Proteins / drug effects
-
Proto-Oncogene Proteins p21(ras)
-
Purines / pharmacology
-
Purines / therapeutic use
-
Pyridines / pharmacology*
-
Pyridines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Receptors, Estrogen / metabolism
-
ras Proteins / drug effects
Substances
-
Aminopyridines
-
Antineoplastic Agents
-
Benzimidazoles
-
KRAS protein, human
-
Piperazines
-
Proto-Oncogene Proteins
-
Purines
-
Pyridines
-
Receptors, Estrogen
-
abemaciclib
-
CDK4 protein, human
-
CDK6 protein, human
-
Cyclin-Dependent Kinase 4
-
Cyclin-Dependent Kinase 6
-
Proto-Oncogene Proteins p21(ras)
-
ras Proteins
-
palbociclib
-
ribociclib